Innovations in imaging for Parkinson’s Disease
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology, Fortrea
Robin Wolz, Chief Scientific Officer at Ixico
Description: This episode features an insightful interview between Fortrea neuroscience leaders and experts from Ixico, focusing on novel imaging biomarkers in Parkinson's disease.
Imaging biomarkers offer valuable insights into Parkinson's disease (PD) progression and can help distinguish it from other conditions. They can be used to identify the disease early, track its progression, and potentially improve clinical care and management.
We discuss the importance of selecting the right biomarkers and explore various imaging approaches that can enhance the accuracy and effectiveness of clinical trials. Listeners will gain a deeper understanding of how these innovations are shaping the future of neuroscience research.
No links were found in this episode’s notes.